Table 2.
Names and metric units of clinical parameters | 320a-3p | 320b | 320c | 320d | 320e |
---|---|---|---|---|---|
BMI (Kg/m2) | -0.37** | ns | ns | ns | ns |
Glucose (mg/dl) | -0.44*** | ns | -0.29* | ns | -0.25* |
HbA1c (mmol/mol) | -0.37* | -0.29* | ns | ns | -0.36* |
TG (mg/dl) | ns | ns | ns | ns | ns |
Chol (mg/dl) | -0.47**** | ns | -0.24* | ns | -0.32** |
HDL-C (mg/dl) | ns | -0.32** | ns | ns | -0.24* |
LDL-C (mg/dl) | -0.38*** | ns | ns | ns | ns |
Leptin (ng/ml) | -0.64**** | ns | ns | ns | ns |
CRP (mg/dl) | ns | ns | ns | -0.33* | ns |
GGT (U/L) | ns | ns | ns | -0.24* | ns |
AST/GOT (U/L) | ns | ns | ns | -0.35** | ns |
ALT/GPT (U/L) | ns | ns | ns | -0.35** | -0.25* |
Correlation analysis was assessed in the total population (LD + OB + HC). The Table reports Spearman r and *P < 0.05, **P < 0.01, ***P < 0.001, ****P < 0.0001, ns significant.